 Thomas Attard
Concepts (319)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenomatous Polyposis Coli | 18 | 2023 | 24 | 5.630 |
Why?
| | Colorectal Neoplasms | 6 | 2024 | 29 | 3.400 |
Why?
| | Child | 55 | 2024 | 3364 | 3.010 |
Why?
| | Humans | 72 | 2024 | 6896 | 2.920 |
Why?
| | Foreign Bodies | 4 | 2024 | 23 | 2.480 |
Why?
| | Adolescent | 35 | 2024 | 2197 | 2.140 |
Why?
| | Neoplastic Syndromes, Hereditary | 5 | 2024 | 6 | 2.100 |
Why?
| | Polyps | 5 | 2024 | 6 | 2.030 |
Why?
| | Gastrointestinal Hemorrhage | 5 | 2020 | 15 | 1.990 |
Why?
| | Endoscopy, Gastrointestinal | 5 | 2024 | 18 | 1.950 |
Why?
| | Colonoscopy | 11 | 2024 | 15 | 1.840 |
Why?
| | Colonic Polyps | 3 | 2023 | 5 | 1.810 |
Why?
| | Child, Preschool | 29 | 2024 | 1569 | 1.800 |
Why?
| | Male | 37 | 2024 | 3337 | 1.790 |
Why?
| | Intestinal Polyposis | 6 | 2024 | 7 | 1.700 |
Why?
| | Female | 36 | 2024 | 3525 | 1.660 |
Why?
| | Capsule Endoscopy | 3 | 2023 | 4 | 1.590 |
Why?
| | Inpatients | 3 | 2022 | 44 | 1.590 |
Why?
| | Autism Spectrum Disorder | 2 | 2024 | 32 | 1.580 |
Why?
| | Endoscopy | 4 | 2020 | 14 | 1.450 |
Why?
| | Stomach Neoplasms | 4 | 2023 | 7 | 1.440 |
Why?
| | Mutation | 10 | 2024 | 212 | 1.420 |
Why?
| | Pediatrics | 5 | 2020 | 186 | 1.410 |
Why?
| | Retrospective Studies | 18 | 2024 | 1296 | 1.330 |
Why?
| | Emergency Service, Hospital | 3 | 2019 | 130 | 1.300 |
Why?
| | Infant | 18 | 2024 | 1446 | 1.220 |
Why?
| | Adult | 14 | 2024 | 1181 | 1.200 |
Why?
| | United States | 9 | 2024 | 669 | 1.100 |
Why?
| | Appendix | 2 | 2023 | 11 | 1.070 |
Why?
| | Genetic Counseling | 4 | 2016 | 9 | 1.060 |
Why?
| | Microbiota | 2 | 2022 | 8 | 1.060 |
Why?
| | Adenomatous Polyposis Coli Protein | 3 | 2018 | 5 | 1.000 |
Why?
| | Proton Pump Inhibitors | 2 | 2023 | 18 | 0.930 |
Why?
| | Cohort Studies | 7 | 2022 | 289 | 0.920 |
Why?
| | Fractures, Bone | 2 | 2022 | 34 | 0.910 |
Why?
| | Databases, Factual | 6 | 2022 | 108 | 0.910 |
Why?
| | Consensus | 4 | 2021 | 35 | 0.870 |
Why?
| | Hospitalization | 3 | 2022 | 210 | 0.870 |
Why?
| | Hospitals, Pediatric | 3 | 2024 | 187 | 0.860 |
Why?
| | Gastrointestinal Neoplasms | 5 | 2019 | 7 | 0.850 |
Why?
| | Colonic Neoplasms | 1 | 2022 | 7 | 0.840 |
Why?
| | Malnutrition | 1 | 2022 | 8 | 0.820 |
Why?
| | Histamine H2 Antagonists | 1 | 2022 | 7 | 0.810 |
Why?
| | Histamine | 1 | 2022 | 13 | 0.800 |
Why?
| | Peutz-Jeghers Syndrome | 4 | 2019 | 5 | 0.790 |
Why?
| | Electronic Health Records | 1 | 2022 | 64 | 0.780 |
Why?
| | Patient Transfer | 1 | 2021 | 8 | 0.770 |
Why?
| | Disease Management | 1 | 2021 | 34 | 0.750 |
Why?
| | Quality of Life | 1 | 2022 | 140 | 0.750 |
Why?
| | Societies, Medical | 1 | 2021 | 51 | 0.750 |
Why?
| | Risk Factors | 6 | 2022 | 487 | 0.730 |
Why?
| | Young Adult | 7 | 2019 | 647 | 0.720 |
Why?
| | Orthodontic Wires | 1 | 2019 | 1 | 0.700 |
Why?
| | Orthodontics | 1 | 2019 | 1 | 0.700 |
Why?
| | Self-Injurious Behavior | 1 | 2019 | 3 | 0.700 |
Why?
| | Endoscopy, Digestive System | 2 | 2018 | 8 | 0.700 |
Why?
| | Biomass | 2 | 2018 | 2 | 0.680 |
Why?
| | Cholecystitis | 1 | 2019 | 6 | 0.680 |
Why?
| | Cathartics | 1 | 2018 | 4 | 0.650 |
Why?
| | Gastrostomy | 1 | 2019 | 63 | 0.650 |
Why?
| | Polyethylene Glycols | 1 | 2018 | 9 | 0.650 |
Why?
| | Genetic Predisposition to Disease | 6 | 2015 | 231 | 0.620 |
Why?
| | Postoperative Complications | 1 | 2019 | 184 | 0.590 |
Why?
| | Genetic Testing | 6 | 2019 | 87 | 0.560 |
Why?
| | Patient Readmission | 1 | 2017 | 68 | 0.550 |
Why?
| | Early Detection of Cancer | 1 | 2016 | 10 | 0.550 |
Why?
| | Age Distribution | 4 | 2019 | 31 | 0.550 |
Why?
| | Length of Stay | 4 | 2022 | 233 | 0.530 |
Why?
| | Intestinal Polyps | 3 | 2019 | 3 | 0.530 |
Why?
| | Treatment Outcome | 6 | 2019 | 622 | 0.520 |
Why?
| | Zea mays | 1 | 2015 | 1 | 0.520 |
Why?
| | Waxes | 1 | 2015 | 1 | 0.520 |
Why?
| | Carbon Dioxide | 1 | 2015 | 14 | 0.520 |
Why?
| | Pedigree | 6 | 2019 | 59 | 0.520 |
Why?
| | Biopsy | 4 | 2022 | 60 | 0.470 |
Why?
| | Eating | 3 | 2024 | 31 | 0.460 |
Why?
| | Age Factors | 4 | 2018 | 210 | 0.440 |
Why?
| | Esophageal Diseases | 1 | 2013 | 1 | 0.440 |
Why?
| | Barrett Esophagus | 1 | 2013 | 2 | 0.440 |
Why?
| | Internship and Residency | 2 | 2015 | 39 | 0.440 |
Why?
| | Collagen | 1 | 2013 | 3 | 0.440 |
Why?
| | Esophagitis | 1 | 2013 | 7 | 0.440 |
Why?
| | Stomach | 1 | 2013 | 11 | 0.440 |
Why?
| | Gastritis | 1 | 2013 | 12 | 0.440 |
Why?
| | Esophagus | 1 | 2013 | 29 | 0.430 |
Why?
| | Adenomatous Polyps | 2 | 2023 | 2 | 0.420 |
Why?
| | Digestive System | 2 | 2024 | 2 | 0.420 |
Why?
| | Genes, APC | 2 | 2015 | 3 | 0.420 |
Why?
| | Phenotype | 4 | 2024 | 257 | 0.400 |
Why?
| | Elective Surgical Procedures | 3 | 2020 | 14 | 0.390 |
Why?
| | Appointments and Schedules | 2 | 2020 | 12 | 0.360 |
Why?
| | Celiac Disease | 3 | 2017 | 3 | 0.360 |
Why?
| | Coronavirus Infections | 2 | 2020 | 15 | 0.360 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 16 | 0.360 |
Why?
| | Duodenal Neoplasms | 2 | 2016 | 2 | 0.360 |
Why?
| | Digestive System Surgical Procedures | 2 | 2020 | 38 | 0.350 |
Why?
| | Crohn Disease | 2 | 2011 | 25 | 0.330 |
Why?
| | Gastrointestinal Diseases | 2 | 2020 | 45 | 0.330 |
Why?
| | Clinical Competence | 1 | 2009 | 29 | 0.320 |
Why?
| | Mass Screening | 2 | 2019 | 35 | 0.320 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2009 | 65 | 0.310 |
Why?
| | Recurrence | 2 | 2019 | 110 | 0.310 |
Why?
| | Cytoskeletal Proteins | 1 | 2007 | 3 | 0.310 |
Why?
| | Colectomy | 4 | 2016 | 14 | 0.310 |
Why?
| | Acute Disease | 2 | 2019 | 79 | 0.310 |
Why?
| | DNA, Neoplasm | 1 | 2007 | 7 | 0.310 |
Why?
| | Comorbidity | 2 | 2019 | 56 | 0.310 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2007 | 2 | 0.310 |
Why?
| | Molecular Biology | 1 | 2007 | 3 | 0.300 |
Why?
| | Time Factors | 2 | 2019 | 250 | 0.290 |
Why?
| | Genetics, Population | 1 | 2007 | 11 | 0.290 |
Why?
| | Prevalence | 3 | 2022 | 146 | 0.280 |
Why?
| | Brain Neoplasms | 1 | 2007 | 45 | 0.280 |
Why?
| | Syndrome | 2 | 2021 | 34 | 0.270 |
Why?
| | Chronic Disease | 2 | 2019 | 105 | 0.270 |
Why?
| | Fibromatosis, Aggressive | 2 | 2016 | 3 | 0.270 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 2 | 2024 | 3 | 0.270 |
Why?
| | Risk Assessment | 3 | 2019 | 137 | 0.260 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 336 | 0.250 |
Why?
| | Abdominal Pain | 2 | 2018 | 71 | 0.250 |
Why?
| | Ileitis | 1 | 2004 | 3 | 0.240 |
Why?
| | Jejunal Diseases | 1 | 2004 | 3 | 0.240 |
Why?
| | Prognosis | 4 | 2007 | 211 | 0.240 |
Why?
| | Nutritional Support | 1 | 2004 | 5 | 0.240 |
Why?
| | Practice Guidelines as Topic | 3 | 2017 | 108 | 0.240 |
Why?
| | Smad4 Protein | 1 | 2024 | 3 | 0.240 |
Why?
| | Neoplasms | 2 | 2019 | 128 | 0.240 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 2024 | 5 | 0.240 |
Why?
| | Health Services Accessibility | 1 | 2024 | 39 | 0.230 |
Why?
| | Intussusception | 2 | 2019 | 12 | 0.220 |
Why?
| | Incidental Findings | 1 | 2023 | 8 | 0.220 |
Why?
| | Patient Selection | 2 | 2020 | 40 | 0.220 |
Why?
| | Hamartoma | 1 | 2003 | 3 | 0.220 |
Why?
| | Pandemics | 2 | 2020 | 82 | 0.220 |
Why?
| | Gastroenterology | 2 | 2019 | 10 | 0.210 |
Why?
| | Ileum | 2 | 2019 | 15 | 0.210 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 17 | 0.210 |
Why?
| | Sex Distribution | 2 | 2018 | 17 | 0.210 |
Why?
| | Health Care Surveys | 2 | 2015 | 33 | 0.210 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2003 | 49 | 0.210 |
Why?
| | Longitudinal Studies | 1 | 2022 | 119 | 0.210 |
Why?
| | Hospitals | 1 | 2022 | 36 | 0.210 |
Why?
| | Electric Power Supplies | 1 | 2021 | 4 | 0.200 |
Why?
| | Enterobacteriaceae Infections | 1 | 2021 | 10 | 0.200 |
Why?
| | Drug Administration Schedule | 2 | 2018 | 35 | 0.200 |
Why?
| | Colitis | 1 | 2021 | 12 | 0.200 |
Why?
| | Stem Cells | 1 | 2021 | 29 | 0.200 |
Why?
| | Appendectomy | 1 | 2023 | 100 | 0.200 |
Why?
| | Diet | 1 | 2021 | 52 | 0.200 |
Why?
| | Adenocarcinoma | 1 | 2001 | 9 | 0.190 |
Why?
| | Pharmacogenetics | 1 | 2023 | 176 | 0.190 |
Why?
| | Algorithms | 4 | 2021 | 105 | 0.190 |
Why?
| | Meckel Diverticulum | 1 | 2020 | 7 | 0.190 |
Why?
| | Obesity | 1 | 2022 | 125 | 0.190 |
Why?
| | Laparoscopy | 2 | 2020 | 207 | 0.180 |
Why?
| | Ileal Diseases | 1 | 2000 | 7 | 0.180 |
Why?
| | Communicable Disease Control | 1 | 2020 | 5 | 0.180 |
Why?
| | Hepatoblastoma | 2 | 2019 | 7 | 0.180 |
Why?
| | Cystic Fibrosis | 1 | 2000 | 18 | 0.180 |
Why?
| | Odds Ratio | 1 | 2020 | 51 | 0.180 |
Why?
| | Personal Autonomy | 1 | 2019 | 1 | 0.180 |
Why?
| | Bioethical Issues | 1 | 2019 | 3 | 0.180 |
Why?
| | Secondary Prevention | 1 | 2019 | 7 | 0.180 |
Why?
| | Mortality | 1 | 2019 | 3 | 0.170 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 31 | 0.170 |
Why?
| | Disease Progression | 1 | 2019 | 111 | 0.170 |
Why?
| | Duodenum | 1 | 2019 | 21 | 0.170 |
Why?
| | Infant, Newborn | 2 | 2019 | 816 | 0.160 |
Why?
| | Enteral Nutrition | 1 | 2019 | 63 | 0.160 |
Why?
| | Steam | 1 | 2018 | 1 | 0.160 |
Why?
| | Phenol | 1 | 2018 | 1 | 0.160 |
Why?
| | Soot | 1 | 2018 | 1 | 0.160 |
Why?
| | Chlorine | 1 | 2018 | 2 | 0.160 |
Why?
| | Laxatives | 1 | 2018 | 5 | 0.160 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2019 | 41 | 0.160 |
Why?
| | Hospital Charges | 1 | 2018 | 11 | 0.160 |
Why?
| | Patient Discharge | 1 | 2019 | 57 | 0.160 |
Why?
| | Social Class | 1 | 2018 | 11 | 0.160 |
Why?
| | Administration, Oral | 1 | 2018 | 58 | 0.160 |
Why?
| | Follow-Up Studies | 3 | 2024 | 304 | 0.160 |
Why?
| | Respiratory Tract Diseases | 1 | 2018 | 7 | 0.160 |
Why?
| | Gastric Mucosa | 2 | 2013 | 14 | 0.160 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 122 | 0.160 |
Why?
| | Fever | 1 | 2018 | 26 | 0.160 |
Why?
| | Urban Population | 1 | 2018 | 27 | 0.160 |
Why?
| | Hypercalcemia | 1 | 1998 | 10 | 0.160 |
Why?
| | Mandibular Neoplasms | 1 | 2018 | 2 | 0.160 |
Why?
| | Osteoma | 1 | 2018 | 2 | 0.160 |
Why?
| | Osteosclerosis | 1 | 2018 | 2 | 0.160 |
Why?
| | Dentofacial Deformities | 1 | 2018 | 2 | 0.160 |
Why?
| | Sex Factors | 1 | 2018 | 68 | 0.160 |
Why?
| | Diphosphonates | 1 | 1998 | 13 | 0.160 |
Why?
| | Patient Compliance | 1 | 2018 | 55 | 0.150 |
Why?
| | Liver Diseases | 1 | 1998 | 18 | 0.150 |
Why?
| | Aged | 3 | 2020 | 378 | 0.150 |
Why?
| | Ambulatory Care | 1 | 2018 | 45 | 0.150 |
Why?
| | Rural Population | 1 | 2018 | 42 | 0.150 |
Why?
| | Double-Balloon Enteroscopy | 1 | 2017 | 1 | 0.150 |
Why?
| | Genotyping Techniques | 2 | 2017 | 22 | 0.150 |
Why?
| | Liver Transplantation | 1 | 1998 | 47 | 0.150 |
Why?
| | Patient Admission | 1 | 2017 | 9 | 0.140 |
Why?
| | Diarrhea, Infantile | 1 | 2017 | 2 | 0.140 |
Why?
| | Multivariate Analysis | 1 | 2017 | 71 | 0.140 |
Why?
| | Liver Neoplasms | 1 | 2016 | 15 | 0.140 |
Why?
| | Vomiting | 2 | 2014 | 23 | 0.140 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2016 | 2 | 0.140 |
Why?
| | Chemoprevention | 1 | 2016 | 4 | 0.140 |
Why?
| | Thyroid Neoplasms | 1 | 2016 | 2 | 0.140 |
Why?
| | Intestinal Mucosa | 1 | 2017 | 41 | 0.140 |
Why?
| | Guideline Adherence | 1 | 2017 | 36 | 0.140 |
Why?
| | Electronic Mail | 1 | 2015 | 2 | 0.130 |
Why?
| | Canada | 1 | 2015 | 31 | 0.130 |
Why?
| | Needs Assessment | 1 | 2015 | 18 | 0.130 |
Why?
| | Plant Leaves | 1 | 2015 | 1 | 0.130 |
Why?
| | Fellowships and Scholarships | 1 | 2015 | 17 | 0.130 |
Why?
| | Curriculum | 1 | 2015 | 22 | 0.130 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 65 | 0.120 |
Why?
| | Evidence-Based Medicine | 3 | 2019 | 48 | 0.120 |
Why?
| | Registries | 2 | 2007 | 92 | 0.120 |
Why?
| | Biopsy, Needle | 2 | 2006 | 3 | 0.120 |
Why?
| | Serologic Tests | 1 | 2014 | 3 | 0.120 |
Why?
| | Genotype | 2 | 2023 | 410 | 0.120 |
Why?
| | Intestine, Small | 1 | 2014 | 15 | 0.120 |
Why?
| | Deglutition Disorders | 1 | 2013 | 1 | 0.110 |
Why?
| | Failure to Thrive | 1 | 2013 | 7 | 0.110 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2013 | 5 | 0.110 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 35 | 0.110 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2013 | 1 | 0.110 |
Why?
| | Chromosome Deletion | 1 | 2013 | 20 | 0.110 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 99 | 0.110 |
Why?
| | Gastric Fundus | 2 | 2023 | 3 | 0.100 |
Why?
| | Dyspepsia | 1 | 2013 | 53 | 0.100 |
Why?
| | Aged, 80 and over | 2 | 2020 | 151 | 0.100 |
Why?
| | Prospective Studies | 3 | 2019 | 525 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2019 | 149 | 0.100 |
Why?
| | Mediterranean Region | 3 | 2017 | 3 | 0.090 |
Why?
| | Radiography, Panoramic | 2 | 2021 | 3 | 0.090 |
Why?
| | Phenylhydrazines | 1 | 2009 | 1 | 0.090 |
Why?
| | Mesalamine | 1 | 2009 | 3 | 0.090 |
Why?
| | Anti-Inflammatory Agents | 1 | 2009 | 11 | 0.090 |
Why?
| | Colon | 1 | 2009 | 14 | 0.090 |
Why?
| | Colitis, Ulcerative | 1 | 2009 | 13 | 0.090 |
Why?
| | Internet | 1 | 2009 | 17 | 0.080 |
Why?
| | Germ-Line Mutation | 1 | 2007 | 10 | 0.080 |
Why?
| | DNA Mutational Analysis | 1 | 2007 | 42 | 0.080 |
Why?
| | Surveys and Questionnaires | 1 | 2009 | 274 | 0.070 |
Why?
| | Codon | 1 | 2007 | 3 | 0.070 |
Why?
| | Asia | 1 | 2007 | 10 | 0.070 |
Why?
| | Europe | 1 | 2007 | 37 | 0.070 |
Why?
| | North America | 1 | 2007 | 44 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2006 | 48 | 0.070 |
Why?
| | Monitoring, Physiologic | 1 | 2006 | 23 | 0.070 |
Why?
| | Transglutaminases | 2 | 2017 | 3 | 0.070 |
Why?
| | GTP-Binding Proteins | 2 | 2017 | 7 | 0.070 |
Why?
| | HLA Antigens | 2 | 2017 | 13 | 0.070 |
Why?
| | Precancerous Conditions | 1 | 2004 | 6 | 0.060 |
Why?
| | Pancreatic Diseases | 1 | 2024 | 1 | 0.060 |
Why?
| | Biliary Tract Diseases | 1 | 2024 | 5 | 0.060 |
Why?
| | Healthcare Disparities | 1 | 2024 | 22 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2004 | 199 | 0.060 |
Why?
| | Cytochrome P-450 CYP2C19 | 1 | 2023 | 60 | 0.050 |
Why?
| | Gastroscopy | 1 | 2002 | 1 | 0.050 |
Why?
| | Maryland | 1 | 2002 | 3 | 0.050 |
Why?
| | Fermentation | 1 | 2021 | 2 | 0.050 |
Why?
| | Pectins | 1 | 2021 | 2 | 0.050 |
Why?
| | Biodiversity | 1 | 2021 | 2 | 0.050 |
Why?
| | Mucin-2 | 1 | 2021 | 2 | 0.050 |
Why?
| | Regeneration | 1 | 2021 | 3 | 0.050 |
Why?
| | Middle Aged | 1 | 2004 | 608 | 0.050 |
Why?
| | Butyrates | 1 | 2021 | 3 | 0.050 |
Why?
| | Citrobacter rodentium | 1 | 2021 | 4 | 0.050 |
Why?
| | Epithelium | 1 | 2021 | 8 | 0.050 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2021 | 8 | 0.050 |
Why?
| | HEK293 Cells | 1 | 2021 | 32 | 0.050 |
Why?
| | Triglycerides | 1 | 2021 | 22 | 0.050 |
Why?
| | Transcription, Genetic | 1 | 2021 | 44 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2021 | 58 | 0.050 |
Why?
| | Promoter Regions, Genetic | 1 | 2021 | 49 | 0.050 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 92 | 0.050 |
Why?
| | Incidence | 1 | 2002 | 133 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2021 | 101 | 0.050 |
Why?
| | Gastrectomy | 1 | 2001 | 1 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 126 | 0.050 |
Why?
| | Triage | 1 | 2020 | 4 | 0.050 |
Why?
| | Cecum | 1 | 2000 | 4 | 0.050 |
Why?
| | Anastomosis, Surgical | 1 | 2000 | 21 | 0.050 |
Why?
| | Mice | 1 | 2021 | 348 | 0.050 |
Why?
| | Symptom Assessment | 1 | 2020 | 13 | 0.050 |
Why?
| | Radiography | 1 | 2000 | 37 | 0.050 |
Why?
| | Gastrointestinal Transit | 1 | 2020 | 1 | 0.040 |
Why?
| | Adenoma | 1 | 2019 | 2 | 0.040 |
Why?
| | Animals | 1 | 2021 | 729 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2019 | 28 | 0.040 |
Why?
| | Sequence Deletion | 1 | 2019 | 12 | 0.040 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2019 | 9 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 150 | 0.040 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 115 | 0.040 |
Why?
| | Osteoclasts | 1 | 1998 | 4 | 0.040 |
Why?
| | Parenteral Nutrition, Total | 1 | 1998 | 6 | 0.040 |
Why?
| | Jaw | 1 | 2018 | 3 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2018 | 215 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2017 | 58 | 0.040 |
Why?
| | Connective Tissue | 1 | 2017 | 2 | 0.040 |
Why?
| | Autoantibodies | 1 | 2017 | 11 | 0.040 |
Why?
| | Health Resources | 1 | 2017 | 17 | 0.040 |
Why?
| | Self Report | 1 | 2016 | 42 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 29 | 0.030 |
Why?
| | Africa, Northern | 1 | 2014 | 1 | 0.030 |
Why?
| | Europe, Eastern | 1 | 2014 | 1 | 0.030 |
Why?
| | Anorexia | 1 | 2014 | 2 | 0.030 |
Why?
| | Antibodies | 1 | 2014 | 15 | 0.030 |
Why?
| | Diarrhea | 1 | 2014 | 18 | 0.030 |
Why?
| | Weight Loss | 1 | 2014 | 39 | 0.030 |
Why?
| | Haplotypes | 1 | 2014 | 91 | 0.030 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2013 | 3 | 0.030 |
Why?
| | PTEN Phosphohydrolase | 1 | 2013 | 6 | 0.030 |
Why?
| | Health Care Costs | 1 | 2011 | 33 | 0.020 |
Why?
| | Aminosalicylic Acids | 1 | 2009 | 1 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2009 | 44 | 0.020 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|